We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-10.49%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$149M
AUM Growth
-$24.6M
Cap. Flow
-$790K
Cap. Flow %
-0.53%
Top 10 Hldgs %
97.09%
Holding
66
New
13
Increased
8
Reduced
17
Closed
27

Top Buys

Rank Stock Value
1
GWAV icon
Greenwave Technology Solutions
GWAV
+$2.42M
2
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$836K
3
APVO icon
Aptevo Therapeutics
APVO
+$567K
4
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$539K
5
SONN
Sonnet BioTherapeutics
SONN
+$402K

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$937K
2
TNXP icon
Tonix Pharmaceuticals
TNXP
+$911K
3
ELTK icon
Eltek
ELTK
+$778K
4
GMM icon
Global Mofy Metaverse
GMM
+$528K
5
RDHL
Redhill Biopharma
RDHL
+$434K

Sector Composition

Rank Sector Weight
1 Healthcare 3.47%
2 Industrials 0.4%
3 Technology 0.27%
4 Materials 0.15%
5 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFTR
26
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$102K 0.07%
+352,084
New +$836K
SMFL
27
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$102K 0.07%
+34,504
New +$117K
CHNR icon
28
China Natural Resources
CHNR
$4.91M
$82.2K 0.06%
13,116
-40,533
-76% -$314K
INM icon
29
InMed Pharmaceuticals
INM
$9.13M
$81.6K 0.05%
15,362
-2,724
-15% -$15.6K
GEVO icon
30
CALL
Gevo
GEVO
$396M
$70.1K 0.05%
1,258
+929
+282% +$622
EOSE icon
31
PUT
Eos Energy Enterprises
EOSE
$1.23B
$64.9K 0.04%
511
+1
+0.2% +$1
SCNI
32
Scinai Immunotherapeutics
SCNI
$1.19M
$49.6K 0.03%
17,828
-7,486
-30% -$31.1K
BNBX
33
DELISTED
BNB PLUS CORP
BNBX
$28.8K 0.02%
+94
New +$241K
SXTPW icon
34
60 Degrees Pharmaceuticals Warrant
SXTPW
$45K
$20.7K 0.01%
295,589
-11,128
-4% -$1.03K
GLBS icon
35
PUT
Globus Maritime Ltd
GLBS
$65M
$17.1K 0.01%
91
-1,365
-94% -$2.8K
WLDSW icon
36
Wearable Devices Ltd Warrant
WLDSW
$13.3K 0.01%
310
-197
-39% -$8.19K
AMPGW
37
DELISTED
Amplitech Group Warrants
AMPGW
$12.8K 0.01%
332,716
-46,328
-12% -$4.86K
SBFM
38
Sunshine Biopharma
SBFM
$3.53M
$8.35K 0.01%
+100
New +$47.7K
CINGW icon
39
Cingulate Inc Warrants
CINGW
$59.6K
$4.95K ﹤0.01%
458,522
-10,200
-2% -$175
AKTX
40
Akari Therapeutics
AKTX
$15.2M
– –
-1,212
Closed -$90.4K
AZTR icon
41
Azitra
AZTR
$2.05M
– –
-2,128
Closed -$87.4K
BCTX
42
Briacell Therapeutics
BCTX
$31.1M
– –
-228
Closed -$97.9K
BCTX
43
PUT
Briacell Therapeutics
BCTX
$31.1M
– –
-2
Closed -$99.8K
BJDX icon
44
Bluejay Diagnostics
BJDX
$1.07M
– –
-117
Closed -$150K
BRTX icon
45
BioRestorative Therapies
BRTX
$7.39M
– –
-168,544
Closed -$233K
CNEY icon
46
CN Energy Group
CNEY
$4.74M
– –
-200
Closed -$5.3K
CORZZ icon
47
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.86B
– –
-14,497
Closed -$34.8K
GCTK icon
48
GlucoTrack
GCTK
$1.91M
– –
-102
Closed -$204K
GMM icon
49
Global Mofy Metaverse
GMM
$5.41M
– –
-855
Closed -$528K
IBIO icon
50
iBio
IBIO
$71M
– –
-14,000
Closed -$56.8K
1
2
3

Similar funds

NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sabby Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sabby Management held 66 positions worth $149M, down 14% from $173M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Sabby Management's Q2 2024 filing shows 13 new, 8 increased, 17 reduced and 27 closed positions. Its largest new stake was Greenwave Technology Solutions: 2,086 shares worth $406K. The largest sale was Vivani Medical, an estimated $937K.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 5.6% a quarter earlier, followed by Industrials and Technology.

  • Sabby Management's largest Q2 2024 buy was Greenwave Technology Solutions: 2,086 shares worth $406K.
  • Sabby Management added most to Lipella Pharmaceuticals in Q2 2024, an estimated $198K increase.
  • Sabby Management's biggest Q2 2024 reduction was Vivani Medical, cutting an estimated $937K.
  • Sabby Management fully exited Tonix Pharmaceuticals in Q2 2024, selling an estimated $911K.
  • Sabby Management's ten largest holdings make up 97% of its $149M portfolio in Q2 2024.
  • Sabby Management opened 13 new positions and closed 27 in Q2 2024.
  • Sabby Management's portfolio value fell 14% quarter-over-quarter to $149M.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.